SCHEMBL18216606

SCHEMBL18216606

CCN[C@H]1Cc2ccc(OC)cc2[C@]2(C)CCCC[C@H]12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 4/20 0.47
▸ GRIN2A Q12879 4/20 0.47
▸ TSHR P16473 3/20 0.47
▸ CYP3A4 P08684 3/20 0.47
▸ CYP2D6 P10635 3/20 0.47
▸ SLC22A1 O15245 2/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ GRIN2D O15399 3/20 0.47
▸ GRIN3B O60391 3/20 0.47
▸ GRIN2B Q13224 3/20 0.47
▸ GRIN2C Q14957 3/20 0.47
▸ GRIN3A Q8TCU5 3/20 0.47
▸ SLC6A4 P31645 2/20 0.47
▸ SIGMAR1 Q99720 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ PMP22 Q01453 2/20 0.47
▸ ADRA2A P08913 1/20 0.47
▸ ADRA2C P18825 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23836805 0.85 GRIN1 (0.47) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334255 0.82 GRIN1 (0.50) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334227 0.81 OPRM1 (0.45) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334250 0.80 GRIN1 (0.44) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL26232267 0.78 GRIN1 (0.47) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL13361592 0.78 GRIN1 (0.47) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334254 0.78 GRIN1 (0.44) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334252 0.77 GRIN1 (0.43) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334256 0.76 GRIN1 (0.43) GRIN1GRIN2ATSHRCYP3A4CYP2D6
SCHEMBL24334251 0.76 GRIN1 (0.42) GRIN1GRIN2ATSHRCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3090760-A1 COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY CONCERT PHARMACEUTICALS, INC. (US) 2016-11-09 — — EP disclosed
Send feedback